In order to transform Malaysia into a country capable of advanced healthcare research and innovation, we will need to have experts with knowledge in both research and clinical/medical fields. Frontline medical doctors, nurses and laboratory personnel do not possess the knowledge in conducting advanced biomedical/biotechnological research. On the other hand, biotechnologists and scientists do not prioritise the needs of frontline medical personnel and thus, they do not fully understand what innovation/products are needed. The Master of Science in Molecular Medicine (MMM) programme is designed and introduced by IMU to fill in this gap.
Learn more about this programme at Molecular Medicine in Pandemic Times (Star, 15 September 2020).
